Abstract
Cell cultures provide a rapid, efficient and economic system for initial cytotoxicity screenings of antitumor agents, allowing elucidation of the mode of action of a drug in a controlled, systematic fashion with a high degree of resolution. The main assumption for in vitro studies with chemotherapeutic agents is that the survival response of cultured cells will reflect that of in vivo cells once the drug reaches the neoplastic elements, thus circumventing the pharmacokinetics determinants of tumor response (i.e. absorption, transportation, combination, transformation and degradation). While a direct translation from in vitro to in vivo systems is not possible, many survival responses of proliferating mammalian cells are reasonably similar to the two situations (1–4) provided that strict criteria are established to define cell survival. Drug-induced cell killing is the result of an interplay between the type, extent, and duration of the damaging effect caused by a drug to critical biosynthetic pathways or subcellular structures and the capacity of living elements to bypass or repair such damage. Because of this interplay, a lethally damaged cell may divide several times before the entire progeny perishes from the damage inherited from the single ancestor (5–8).
Supported by Grant CA16763 through the National Large Bowel Cancer Project and Grants CA14528 and CA23272 through the National Cancer Institute, NIH, DHEW.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
B. K. Bhuyan, Cancer Res. 30: 2013–2017 (1970).
H. Madoc-Jones and F. Mauro, J. Nat. Cancer Inst. 45: 1131–1143 (1970).
T. Kaneko and G.A. Le Page, Cancer Res. 38: 2084–2090 (1978).
M. L. Rosenblum, K. T. Wheeler, C. B. Wilson, M. Barker and K. D. Kuebel, Cancer Res. 35: 1387–1391 (1975).
C. G. Whitmore and J. E. Till, Annual Rev. Nucl. Sci. 14: 347–374 (1964).
L. H. Thompson and H. D. Suit, Int. J. Rad. Biol. 13: 347–362 (1969).
S. Peel and D. M. Cowen, Brit. J. Cancer, 26: 304–314 (1972).
U. K. Ehmann and K. T. Wheeler, Eur. J. Cancer, 15: 461–473 (1979).
B. Drewinko and B. Barlogie, Cancer Treat. Rep. 60: 1707–1717 (1976).
B. Barlogie and B. Drewinko, Eur. J. Cancer, 14: 741–745 (1978).
H. Madoc-Jones and F. Mauro, in: “Handbook of Experimental Pharmacology”, A. C. Sartorelli and D. G. Johns, editors, Springer, Germany, pp. 205–219 (1975).
P. Roper and B. Drewinko, Cancer Res., 36: 2182–2188 (1976).
B. Drewinko, P. R. Roper and B. Barlogie, Eur. J. Cancer, 15: 93–99 (1979).
B. K. Bhuyan, B. E. Loughman, T. J. Fraser, and K. J. Day, Expt. Cell Res., 97: 275–280 (1976).
T. T. Puck and P. I. Marcus, Proc. Natl. Acad. Sci., 41: 432–437 (1955).
A. W. Nias and M. Fox, Br. J. Radiol. 41: 468–474 (1968).
G. G. Steel, in: “Growth Kinetics of Tumours”, Clarendon Press, Oxford, (1977).
O. I. Epifanova and V. V. Terskikh, Cell Tissue Kinet. 2: 75–93 (1969).
M. F. Rajewsky, in: “Recent Results in Cancer Research”, Grundmann and R. Gross, editors, Springer, Germany, pp. 156–171 (1975).
S. C. Barranco and J. K. Novak, Cancer Res. 34: 1616–1818 (1974).
W. R. Bruce, B. E. Meeker and F. A. Valeriote, J. Natl. Cancer Inst., 37: 233–245 (1966).
B. K. Bhuyan, T. J. Fraser and K. J. Day, Cancer Res. 37: 1057–1063 (1977).
O. I. Epifanova, I. N. Smolenskaya and V. A. Polunovsky, Br. J. Cancer, 37: 377–385 (1978).
F. Valeriote and L. van Putten, Cancer Res., 35: 2619–2630 (1975).
L. M. van Putten, Cell Tissue Kinet. 7: 493–504 (1974).
L. M. van Putten and P. Lelieveld, Eur. J. Cancer, 7: 11–16 (1971).
L. M. van Putten, P. Lelieveld and L. K. J. Kram Idsenga, Cancer Chemoth. Repts., 56: 691–700 (1972).
S. C. Barranco, W. E. Bolton and J. K. Novak, 12: 11–16 (1979).
S. C. Barranco, J. K. Novak and R. M. Humphrey, Cancer Res. 33: 691–694 (1973).
E. Olah, I. Palyi and J. Sugar, Eur. J. Cane. 14: 895–900 (1978).
G. M. Hahn and L. B. Little, Current Topics Radiation Res. 8: 39–83 (1972).
F. Mauro, B. Falpo, G. Briganti, R. Elli and G. Zupi, J. Natl. Cancer Inst. 52: 705–713 (1974).
F. Mauro and H. Madoc-Jones, Cancer Res., 30: 1397–1408 (1970).
B. K. Bhuyan, L. G. Scheidt and T. J. Fraser, Cancer Res. 32: 398–407 (1972).
J. M. Trujillo, B. Drewinko and M. J. Ahearn, Cancer Res. 32: 1057–1065 (1972).
B. Drewinko, M. M. Romsdahl, L. Y. Yang, M. J. Ahearn and J. M. Trujillo, Cancer Res., 36: 467–475 (1976).
B. Drewinko, L. Y. Yang, B. Barlogie, M. M. Romsdahl, M. Meistrich, M. A. Malahy and B. Giovanella, J. Natl. Cancer Inst., 61: 75–83 (1978a).
J. J. Stragand, J. P. Bergerat, R. A. White, J. Hokanson and B. Drewinko, Cancer Res., (In Press).
B. Drewinko, B. Bobo, P. R. Roper, M. A. Malahy, B. Barlogie and B. Jansson, Cell Tiss. Kinet. 11: 191–197 (1978).
B. D. Clarkson in: “Control of Proliferation in Animal Cells” B. Clarkson and R. Baserga, editors, Cold Spring Harbor Press, Maryland, p. 945 (1974).
M. Tubiana, M. Guichard and E. P. Malaise, in: “Growth Kinetics and Biochemical Regulation of Normal and Malignant Cells” B. Drewinko and R. M. Humphrey, editors, William and Wilkins, Baltimore, pp. 827–842 (1977).
G. C. Zubrod, Can. Conf., 8: 31–39 (1969).
O. I. Epifanova, Int. Rev. Cytol. 5: 303–335 (1977).
H. Ian, Cancer Res., 33: 1716–1720 (1973).
R. F. Pittillo, F. M. Schabel, Jr. and H. E. Skipper, Cancer Chemoth. Rept., 54: 137–142 (1970).
G. R. Ray, G. M. Hahn, M. A. Bagshaw and S. Kurkjian, Cancer Chemoth. Rept. 57: 473–475 (1973).
F. M. Schabel, Jr., Cancer Res., 29: 2384–2389 (1969).
F. M. Schabel, Jr., H. E. Skipper, M. W. Trader and W. D. Wilcox, Cancer Chemoth. Rept., 48: 17–30 (1965).
L. J. Wilkoff, H. H. Lloyd and F. A. Dulmadge, Chemotherapy, 16: 44–60 (1971).
R. F. Hagemann, L. L. Schenken and S. Lesher, J. Natl. Cancer Inst. 50: 467–474 (1973).
G. M. Hahn, Nature, 247: 741–742 (1968).
G. M. Hahn, G. R. Ray, D. E. Gordon and R. F. Kallman, J. Natl. Cancer Inst. 50: 529–533 (1973).
B. Papirmeister, C. L. Davidson, Biochem. Biophys. Acta, 103: 70–92 (1965).
J. J. Roberts, T. P. Brent and A. R. Crathorn, Eur. J. Cancer 7: 515–524 (1971).
F. A. Valeriote, D. Vieth and S. Tolen, Cancer Res., 33: 2658–2661 (1973).
G. M. Hahn, D. E. Gordon, S. D. Kurkjian, Cancer Res., 34: 2373–2377 (1974).
F. Mauro, B. Falpo, G. Briganti, R. Elli and G. Zupi, J. Natl. Cancer Inst. 52: 715–722 (1974).
R. M. Sutherland, Cancer Res., 34: 3501–3503 (1974).
C. J. Thatcher and I. G. Walker, J. Natl. Cancer Inst. 42: 363–368 (1969).
P. R. Twentyman and N. M. Bleehen, Brit. J. Cancer, 28: 500–507 (1973).
A. B. Pardee, Proc. Natl. Acad. Sci. 71: 1286 (1974).
R. A. Tobey and K. D. Ley, J. Cell Biol., 46: 151–157 (1970).
A. D. Glinos and R. J. Werrlem, J. Cell Physiol. 79: 79–90 (1972).
A. Kouns, Expl. Cell Res., 94: 15–22 (1975).
P. R. Twentyman and N. M. Bleehen, Br. J. Cancer, 31: 68–74 (1975).
H. Madoc-Jones and W. R. Bruce, Nature 215: 302–303 (1967).
B. Drewinko, B. Barlogie, W. Mars, M. A. Malahy and B. Jansson Cell Tissue Kinet. 12: 675 (1979).
A. Macieira-Coelho, Proc. Soc. Exp. Biol. Med., 125: 548–552 (1967).
D. W. Ross and W. K. Sinclair, Cell Tissue Kinet. 5: 1–14 (1972).
S. Gelfant, Cancer Res., 37: 3845–3862 (1977).
B. Barlogie, P. Corry and B. Drewinko, Cancer Res., 40: 1165–1168 (1980).
B. T. Hill in: “Current Chemotherapy and Infectious Disease” J. D. Nelson and C. Grassi, editors, American Society of Microbiology, Washington, pp. 1571–1573 (1980).
N. M. Blackett and K. Adams, Br. J. Haematol. 23: 751–758 (1972).
S. K. Lahiri, Cell Tissue Kinet. 6: 509–514 (1973).
M. Karon and S. Shirakawa, Cancer Res., 29: 687–696 (1969).
J. H. Kim, A. G. Perez and B. Djordjevic, Cancer Res., 28: 2443–2447 (1968).
W. C. Lambert and G. Studzinsky, Cancer Res., 27: 2364–2369 (1967).
S. Brachetti and G. F. Whitmore, Cell Tiss. Kinet. 2: 193–211 (1969).
H. Madoc-Jones and F. Mauro, Cell Physiol. 185–196 (1969).
S. C. Barranco and R. M. Humphrey, Cancer Res., 31: 191–195 (1971).
I. Tannock and E. Frei, Natl. Cancer Inst. Monograph, 34: 19–23 (1971).
B. Drewinko and R. Alexanian, J. Natl. Cancer Inst. 58: 1247–1253 (1977).
H. E. Skipper, Cancer, 28: 1479–1492 (1971).
L. A. Dethlefsen, Int. J. Rad. Oncology Biol. Phys. 5: 1197–1203 (1979).
L. A. Dethlefsen, S. P. Sorensen and R. M. Riley, Cancer Res. 35: 694–699 (1975).
J. J. Stragand, B. Drewinko, P. G. Braunschweiger, H. R. Jacob and L. M. Schiffer, Eur. J. Cancer, 16: 293–295 (1980).
B. Barlogie, B. Drewinko, G. Dosik and E. J, Freireich, Acta Path. Microbiol. Scand. (In Press)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 Plenum Press, New York
About this chapter
Cite this chapter
Drewinko, B., Barlogie, B. (1982). The Relevance of Cell Kinetics in Determining Drug Activity in vitro. In: Nicolini, C. (eds) Cell Growth. NATO Advanced Study Institutes Series, vol 38. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4046-1_35
Download citation
DOI: https://doi.org/10.1007/978-1-4684-4046-1_35
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-4048-5
Online ISBN: 978-1-4684-4046-1
eBook Packages: Springer Book Archive